Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2010
12/30/2010US20100330593 Methods and compositions for diagnosing neoplastic disease
12/30/2010US20100330590 Assays using chimeric t1r3 taste receptor polypeptides
12/30/2010US20100330583 Compositions and methods for identification of PARP function, inhibitors, and activators
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330113 Vaccine Antigens
12/30/2010US20100330108 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
12/30/2010US20100330107 Antibody drug conjugates (adc) that bind to 24p4c12 proteins
12/30/2010US20100330104 Methods of using btl-ii proteins
12/30/2010US20100330103 Antibodies Directed to Alpha V Beta 6 And Uses Thereof
12/30/2010US20100330102 Immunoglobulin preparation for the treatment of hiv-1 infection
12/30/2010US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710
12/30/2010US20100330098 Methods to regulate glucose metabolism
12/30/2010US20100330096 Methods of treating diseases with anti-vegf antibodies
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330094 Anti-IP-10 Antibodies and Methods of Use Thereof
12/30/2010US20100330092 Monoclonal antibody having neutralizing activity against mmp13
12/30/2010US20100330091 Immunoreactive glycoprotein gp19 ehrlichia canis
12/30/2010US20100330090 Antagonist antibodies of protease activated receptor-1 (par1)
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
12/30/2010US20100330084 Single domain vhh antibodies against von willebrand factor
12/30/2010US20100330080 Antigen binding polypeptides
12/30/2010US20100330078 Alpha 5 - beta 1 antibodies and their uses
12/30/2010US20100330076 Immunoglobulin fc polypeptides
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330074 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
12/30/2010US20100330073 Methods of treatment using antibodies to neutrokine-alpha
12/30/2010US20100330071 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100329990 Luminescent markers
12/30/2010US20100329987 Uses of Sperm Membrane Protein OBF
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/30/2010US20100329930 Streptavidin macromolecular adaptor and complexes thereof
12/29/2010WO2010151792A1 Readily isolated bispecific antibodies with native immunoglobulin format
12/29/2010WO2010151770A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent
12/29/2010WO2010151656A2 Compositions and methods for identification of parp function, inhibitors, and activators
12/29/2010WO2010151632A1 Protein purifacation by caprylic acid (octanoic acid ) precipitation
12/29/2010WO2010151526A1 Bispecific antibodies that bind to complement proteins
12/29/2010WO2010149641A2 Pharmaceutical agent
12/29/2010WO2010149355A1 Immunoglobulin preparation for the treatment of hiv-1 infection
12/29/2010WO2010102792A9 Human antibodies against human fas and their use
12/29/2010WO2010083253A3 Cd47 related compositions and methods for treating immunological diseases and disorders
12/29/2010WO2010068278A3 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
12/29/2010EP2267457A1 Beta 2-microglobulin biomarker for diagnosing diabetic retinopathy
12/29/2010EP2267450A2 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
12/29/2010EP2267448A1 Composition, kit and method for detecting neuropathy
12/29/2010EP2267447A1 Composition, kit and method for detecting aging and disease associated with vascular disorder
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267154A1 Oligoadenylate synthetase
12/29/2010EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination
12/29/2010EP2267130A2 Bitter taste receptors
12/29/2010EP2267129A2 Bitter taste receptors
12/29/2010EP2267128A2 Bitter taste receptors
12/29/2010EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor
12/29/2010EP2267117A2 Differentiation modulating agents and uses therefor
12/29/2010EP2267113A1 Culture medium for Neisseria meningitidis with soy bean extract as amino acid source and no protein complexes of animal origin
12/29/2010EP2267034A2 Gold-binding protein and use thereof
12/29/2010EP2267033A2 Gold-binding protein and use thereof
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267031A1 Endothelial cell specific antibodies and uses thereof
12/29/2010EP2267030A1 Devices, compositions and methods for the protection and repair of cells and tissues
12/29/2010EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents
12/29/2010EP2267028A2 DUAL SPECIFIC SINGLE DOMAIN ANTIBODIES (dAb) conjugated to PEG
12/29/2010EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267013A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267012A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267011A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267006A1 Enterococcus antigens
12/29/2010EP2267005A1 ADP-ribosylating toxin from Listeria monocytogenes
12/29/2010EP2267004A2 Peptide derived from hepatitis C virus
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266616A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266615A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266613A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266612A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266607A2 Immunoconjugates for treating cancer
12/29/2010EP2266606A1 Methods and compositions for the prevention and treatment of sepsis
12/29/2010EP2266592A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
12/29/2010EP2266591A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
12/29/2010EP2265646A1 Reagents and methods for detecting influenza virus proteins
12/29/2010EP2265644A1 A monoclonal antibody and a method thereof
12/29/2010EP2265643A1 Agent for treating disease
12/29/2010EP2265642A1 Biomarkers
12/29/2010EP2265641A1 Biomarkers
12/29/2010EP2265640A2 Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
12/29/2010EP2265639A1 Compositions comprising antibodies or antibody fragments
12/29/2010EP2265636A1 Mzb1, a novel b cell factor, and uses thereof
12/29/2010EP2265634A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
12/29/2010EP2265288A1 Methods of treating inflammatory pain
12/29/2010EP2265287A1 Methods of treating chronic pain
12/29/2010EP1987066B1 Methods for treating demyelinating diseases
12/29/2010EP1856153B1 Ykl-40 monoclonal antibodies
12/29/2010EP1828249B1 Biomarkers for pre-selection of patients for anti-igf1r therapy
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1494